Zarzatech is a specialized pharmaceutical company focus on the development of Periodontal products. R&D in the US and Europe.
Zarzatech is focused on the prevention and treatment of Oral inflammatory diseases, unmet need in 80% of the population. Zarzatech is focused on the development of a platform medical device products, non-invasive with a triple action at the Oral mucosa barrier, preventing the progression of Gingivitis and periodontitis. Efficacy proven and studied in humans up to phase II trials.Experts in strategies bringing a product to the market in one year